Abstract
Zolpidem is a hypnotic drug from imidazopyridine family that is chemically distinct from classic benzodiazepines (BDZ). Contrary to classic BDZ, zolpidem acts selectively on α 1 subunit-containing GABA-A benzodiazepine (BZ1) receptors. There are a considerable number of zolpidem dependence case reports in the recent psychiatric literature. Regarding the similarities of zolpidem and BDZ in pharmacodynamic and addictive characteristics, writers posits that recommended detoxification protocols for short half-life BDZ, may also be useful in high doses zolpidem withdrawal symptoms management. Safety and effectiveness of phenobarbital for inpatient BDZ detoxification has been established in previous researches and it may be useful for zolpidem detoxification.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
